WASHINGTON (Reuters) - A Jazz Pharmaceuticals Inc medicine is effective for treating fibromyalgia but it is unclear whether the company’s proposed safeguards would adequately minimize misuse, U.S. drug reviewers said in documents released on Wednesday.
